Clinical Trial Update: Ocular Inflammation in Cataract Patients and Response to Treatment With Xiidra [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating ocular inflammation in cataract patients and response to Xiidra has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye

Drugs mentioned

• Xi-idra (lifitegrast)

Snippet

Sponsor: Bucci Laser Vision Institute | Conditions: Dry Eye | Phase 4 | Status: WITHDRAWN